Early treatment with inclisiran for heart attack patients
Treatments studied
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests if starting inclisiran soon after a heart attack helps lower cholesterol further in patients already on statins. The goal is to see if early treatment can reduce future heart risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are hospitalized for a heart attack (STEMI or NSTEMI).
- You had a procedure to open the blocked artery (angioplasty with or without a stent) or are being treated with medications alone.
- Your LDL (bad) cholesterol is at a certain level, depending on what cholesterol medication you were taking before.
- You can be randomized (assigned to a group) within 7 days of being admitted to the hospital for this heart attack.
- You are not in cardiogenic shock, have unstable blood pressure or heart rhythm, or severe heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding inclisiran to standard care can lower LDL cholesterol more than standard care alone in people who recently had a heart attack or unstable angina. It aims to help patients in Saudi Arabia reduce their risk of future heart problems.
This study looks at how to best coordinate care between your regular doctor and heart specialists if you have chronic heart disease. It tests whether a special program helps you stay on the right medications to lower cholesterol.
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
This study tests a cholesterol-lowering injection (inclisiran) given soon after a heart attack, urgent heart procedure, or stroke. The goal is to see if it helps lower bad cholesterol quickly and safely.
This study tests a new injectable medicine called inclisiran for people who are already on many medications and have high cholesterol. It is designed for those who cannot lower their cholesterol enough with statins, especially if they have diabetes or other heart risks.
This trial tests if adding inclisiran to your current statin can reduce dangerous, rupture-prone plaque in your heart arteries. It may help if you have a moderate blockage with thin-cap plaque and your LDL cholesterol stays high despite statins.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.